Home/Celcuity/Lance Laing, PhD
LL

Lance Laing, PhD

Chief Science Officer and Co-founder

Celcuity

Celcuity Pipeline

DrugIndicationPhase
GedatolisibHR+/HER2- Advanced Breast Cancer (post-CDK4/6i)Phase 3